When.com Web Search

  1. Ad

    related to: pfizer opportunities and threats

Search results

  1. Results From The WOW.Com Content Network
  2. Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent ...

    www.aol.com/pfizer-eyes-20-billion-revenue...

    On the cost side, Pfizer achieved $4 billion in savings and announced an additional $1.5 billion in margin improvements. In R&D, leadership changed for the first time in 15 years,

  3. Why I'm Considering Leaning Heavily Into Pfizer - AOL

    www.aol.com/why-im-considering-leaning-heavily...

    This diverse pipeline provides multiple opportunities for future growth. Near-term headwinds create opportunity Pfizer faces near-term challenges as COVID-19 product sales decline.

  4. Pfizer (PFE) Q3 2024 Earnings Call Transcript - AOL

    www.aol.com/pfizer-pfe-q3-2024-earnings...

    Pfizer (NYSE: PFE) Q3 2024 Earnings Call Oct 29, 2024, 10:00 a.m. ET. ... We are prioritizing opportunities where we have scientific leadership and deep capabilities to address significant unmet ...

  5. Pfizergate - Wikipedia

    en.wikipedia.org/wiki/Pfizergate

    Pfizergate refers to a scandal involving European Commission President Ursula von der Leyen and the American pharmaceutical company Pfizer over the procurement of COVID-19 vaccines. The controversy centers on the lack of transparency in the communication and negotiation processes for purchasing a significant number of vaccine doses during the ...

  6. Parke-Davis - Wikipedia

    en.wikipedia.org/wiki/Parke-Davis

    Parke-Davis is a subsidiary of the pharmaceutical company Pfizer. Although Parke, Davis & Co. is no longer an independent corporation, it was once America's oldest and largest drug maker, and played an important role in medical history. In 1970 Parke-Davis was acquired by Warner–Lambert, which in turn was acquired by Pfizer in 2000. [2]

  7. Big Pharma: Why the drug industry faces a 3-front ... - AOL

    www.aol.com/finance/big-pharma-why-drug-industry...

    It asked for more details and more closely scrutinized Pfizer’s $43 billion acquisition of Seagen, ultimately allowing the deal to go through. (Pfizer received approval this week and will close ...

  8. List of largest pharmaceutical mergers and acquisitions

    en.wikipedia.org/wiki/List_of_largest...

    Pfizer: Astra Zeneca: 99 127 AstraZeneca claimed the deal undervalued the company. [16] 5 1999 Pfizer: Warner–Lambert: 82.4 151 Pfizer made a hostile bid, just after the announcement of a $72 billion deal with Wyeth, the eventual purchase price would be in excess of $90 billion. [17] [18] [19] 6 1999 Wyeth: Warner–Lambert: 72 132

  9. The faulty forecasts of pharma firm investors: Misguided ...

    www.aol.com/finance/faulty-forecasts-pharma-firm...

    Of course, there are some cynics who take a “show-me” attitude, and fortunately for those cynics, a catalyst-rich 2025 will provide no shortage of potential sparkplugs, including the release ...